PharmaVOICE Blog Post

Why do so many clinical trials fail at start-up?

Posted By: Dan Limbach
October 23, 2019

Nearly 80% of clinical trials fail to meet their activation timelines. But why does the start-up process fail us this often? This question can be answered by implementing a Feasibility Maturity Model with six critical variables.

Understand the 6 key variables: bit.ly/2IORt0c

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK